Rapid Micro Biosystems, Inc. Class A RPID 深 沪
已收盘 07-17 16:00:00 美东时间
2.07
-0.020
-0.96%
华盛通- 最 高2.09
- 今 开2.08
- 成交量 13.91万股
- 最 低 2.00
- 昨 收 2.09
- 总市值 1.02亿
- 52周最高 4.94
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 1.66
- 委 比 37.60%
- 总股本 4941.96万
- 历史最高 27.04
- 量 比 0.37
- 振 幅 4.31%
- 历史最低 0.58
- 每 手 1
- 风险率 0.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Susquehanna上调美光目标价从600美元升至1750美元；戴尔、MongoDB、网泰信息存储、Nextpower、Okta等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从7美元升至7.5美元；Susquehanna：维持美光科技"积极"评级，目标价从600美元升至1750美元
06-01 14:11
Keybanc Maintains Overweight on Rapid Micro Biosystems, Lowers Price Target to $5
Keybanc analyst Paul Knight maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Overweight and lowers the price target from $8 to $5.
05-29 23:49
Lake Street Maintains Buy on Rapid Micro Biosystems, Lowers Price Target to $7
Lake Street analyst Thomas Flaten maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Buy and lowers the price target from $8 to $7.
05-22 23:02
Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript
Rapid Micro Biosystems (NASDAQ:RPID) released first-quarter financial results a...
05-14 05:31
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.225M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.225 million estimate.
05-14 04:34
Rapid Micro Biosystems Q1 EPS $(0.31) Misses $(0.23) Estimate, Sales $8.002M Beat $7.600M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 19.23 percent decrease over losses of $(0.26) per
05-14 04:33
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Rapid Micro Biosystems shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint below estimates.
Rapid Micro Biosystems shares are trading lower after the company reported wors...
03-12 21:25
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Rapid Micro Biosystems Sees FY2026 Sales $37.000M-$41.000M vs $40.125M Est
Rapid Micro Biosystems (NASDAQ:RPID) sees FY2026 sales of $37.000 million-$41.000 million vs $40.125 million analyst estimate.
03-12 19:06
